Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Combination images of Democratic presidential candidate Joe Biden and actor-comedian Jim Carrey.

Jim Carrey will play Joe Biden when "Saturday Night Live" returns for its 46th season next month, NBC confirmed in an emailed statement Wednesday.

The big picture: The show is due to return Oct. 3. "'SNL' is planning to have a limited in-studio audience at Rockefeller Center for the upcoming season," a spokesperson said. The show "will work closely" with New York Gov. Andrew Cuomo's team to ensure it meets requirements to protect against COVID-19, the spokesperson added. "SNL" was produced remotely earlier this year due to the pandemic.

Go deeper

Updated Nov 10, 2020 - Science

Theta becomes 29th named storm in record hurricane season

A satellite image of Subtropical Storm Theta. Photo: National Hurricane Center/Twitter

Subtropical Storm Theta formed in the Northeast Atlantic Monday night, becoming the 29th named storm of the 2020 hurricane season, the National Hurricane Center confirmed.

Why it matters: The formation of Theta, which was some 995 miles southwest of the Azores overnight, breaks the record for the most named storms in a season — set in 2005. The World Meteorological Organization sets 21 alphabetical names for every season (excluding Q,U, X, Y and Z). This is the second time ever it's used all and had to turn to the Greek alphabet.

Editor's note: This article has been updated with further context on the hurricane season.

USAID chief tests positive for coronavirus

An Air Force cargo jet delivers USAID supplies to Russia earlier this year. Photo: Mikhail Metzel/TASS via Getty Images

The acting administrator of the United States Agency for International Development informed senior staff Wednesday he has tested positive for coronavirus, two sources familiar with the call tell Axios.

Why it matters: John Barsa, who staffers say rarely wears a mask in their office, is the latest in a series of senior administration officials to contract the virus. His positive diagnosis comes amid broader turmoil at the agency following the election.

Bryan Walsh, author of Future
3 hours ago - Health

COVID-19 shows a bright future for vaccines

Illustration: Annelise Capossela/Axios

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.